Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of RNA Force Fields for Dynamic Docking of Small Molecules Using Multicanonical MD Simulations.

Journal of chemical theory and computation·2025
Same author

Investigation on the Substrate Specificity of Serine Protease Neuropsin by Molecular Dynamics Simulation and Marmoset Gene Atlas (MGA).

ACS omega·2025
Same author

A virtual system-coupled molecular dynamics simulation free from experimental knowledge on binding sites: Application to RNA-ligand binding free-energy landscape.

Biophysics and physicobiology·2025
Same author

Binding free-energy landscapes of small molecule binder and non-binder to FMN riboswitch: All-atom molecular dynamics.

Biophysics and physicobiology·2024
Same author

Binding Mechanism of Riboswitch to Natural Ligand Elucidated by McMD-Based Dynamic Docking Simulations.

ACS omega·2024
Same author

A cutoff-based method with charge-distribution-data driven pair potentials for efficiently estimating electrostatic interactions in molecular systems.

The Journal of chemical physics·2023

Related Experiment Video

Updated: Jun 23, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Structure-based drug screening and ligand-based drug screening with machine learning.

Yoshifumi Fukunishi1

  • 1Biomedicinal Information Research Center, National Institute of Advanced Industrial Science and Technology, 2-41-6 Aomi, Koto-ku, Tokyo, Japan. y-fukunishi@aist.go.jp

Combinatorial Chemistry & High Throughput Screening
|May 16, 2009
PubMed
Summary

Machine learning enhances virtual drug screening by improving accuracy and reducing computational costs. This approach boosts the discovery of novel drug candidates, addressing limitations in traditional methods.

Related Experiment Videos

Last Updated: Jun 23, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Machine learning applications

Background:

  • In silico screening is crucial for early drug development but faces challenges with low hit ratios and high computational costs.
  • Structure-based screening struggles with accurate binding free energy estimation, while ligand-based methods like quantitative structure-activity relationship (QSAR) have limited success with novel scaffolds.

Purpose of the Study:

  • To review machine learning (ML) approaches for improving both structure-based and ligand-based in silico drug screening.
  • To highlight how ML addresses the limitations of conventional virtual screening techniques.

Main Methods:

  • Machine learning is applied to enhance database enrichment in virtual screening.
  • Two primary ML strategies are discussed: improving docking scores and optimizing feature vector distances between active and inactive compounds.
  • These methods utilize protein-compound affinity data and various molecular descriptors.

Main Results:

  • Machine learning improves the accuracy of predicting protein-compound interactions, leading to higher hit ratios.
  • ML methods enhance the effectiveness of both structure-based and ligand-based screening approaches.
  • The application of ML allows for better identification of new hit compounds, including those with novel chemical structures.

Conclusions:

  • Machine learning offers a powerful solution to overcome the limitations of traditional in silico drug screening.
  • ML-driven approaches significantly improve the efficiency and success rate of identifying potential drug candidates.
  • The review underscores the growing importance of ML in modern drug discovery pipelines.